isoproterenol has been researched along with betaine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Anandan, R; AnbinEzhilan, R; Buddhan, S; Ganesan, B; Sivakumar, R | 1 |
| Anandan, R; Ganesan, B | 1 |
| Anandan, R; Buddhan, S; Ganesan, B; Jeyakumar, R | 1 |
| Dai, G; Liu, J; Mai, S; Wang, Y; Yuan, Y; Zheng, P | 1 |
| Babaei, G; Ghartavol, MM; Gholizadeh-Ghaleh Aziz, S; Hassan Khadem Ansari, M; Hossein Farjah, G | 1 |
| Fernández-Fígares, I; Lachica, M; Martínez-Pérez, M; Ramsay, TG | 1 |
1 review(s) available for isoproterenol and betaine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for isoproterenol and betaine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Aspartate Aminotransferases; Betaine; Catalase; Creatine Kinase; Glutathione Transferase; Homocysteine; Isoproterenol; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; Spectrophotometry, Ultraviolet; Superoxide Dismutase | 2010 |
Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats.
Topics: Acid Phosphatase; Animals; Betaine; Cardiotonic Agents; Enzyme Activation; Glycoside Hydrolases; Heart; Isoproterenol; Lipid Peroxidation; Lipotropic Agents; Lysosomes; Male; Myocardial Infarction; Rats | 2009 |
Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats.
Topics: Adenosine Triphosphatases; Animals; Betaine; Calcium; Cardiotonic Agents; Isoproterenol; Lipid Peroxidation; Male; Membranes; Minerals; Myocardial Infarction; Myocardium; Potassium; Rats; Rats, Wistar; Sodium; Sulfhydryl Compounds | 2009 |
Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats.
Topics: Animals; Apoptosis; Betaine; Biomarkers; Cardiotonic Agents; Dose-Response Relationship, Drug; Isoproterenol; Male; Myocardial Infarction; Rats, Sprague-Dawley; STAT3 Transcription Factor; Troponin I | 2015 |
The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat.
Topics: Animals; Betaine; Cardiotonic Agents; Isoproterenol; Kidney; Male; Myocardial Infarction; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Renal Insufficiency; Tumor Necrosis Factor-alpha | 2019 |
Conjugated linoleic acid and betaine affect lipolysis in pig adipose tissue explants.
Topics: Adipose Tissue; Animals; Betaine; Glycerol; Insulin; Insulin Antagonists; Isoproterenol; Leptin; Linoleic Acids, Conjugated; Lipolysis; Male; Swine | 2019 |